Comparison of driving simulator performance with real driving after alcohol intake: A randomised, single blind, placebo-controlled, cross-over trial  by Helland, Arne et al.
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The  purpose  of this  study  was  to establish  and  validate  a driving  simulator  method  for  assessing  drug
effects  on  driving.  To  achieve  this,  we  used  ethanol  as a positive  control,  and  examined  whether  ethanol
affects  driving  performance  in  the simulator,  and  whether  these  effects  are  consistent  with performance
during  real  driving  on  a test  track,  also under  the  inﬂuence  of  ethanol.  Twenty  healthy  male  volunteers
underwent  a total  of  six  driving  trials  of  1  h  duration;  three  in an  instrumented  vehicle on  a  closed-
circuit  test  track  that  closely  resembled  rural  Norwegian  road  conditions,  and  three  in the  simulator
with  a driving  scenario  modelled  after  the  test  track.  Test  subjects  were  either  sober  or titrated  to blood
alcohol  concentration  (BAC)  levels  of  0.5 g/L  and  0.9  g/L. The  study  was  conducted  in a randomised,  cross-
over, single-blind  fashion,  using  placebo  drinks  and  placebo  pills  as  confounders.  The primary  outcome
measure  was  standard  deviation  of  lateral  position  (SDLP;  “weaving”).  Eighteen  test  subjects  completed
all  six driving  trials,  and  complete  data  were  acquired  from  18 subjects  in  the  simulator  and  10  subjects
on  the  test  track,  respectively.  There  was  a positive  dose–response  relationship  between  higher  ethanol
concentrations  and  increases  in  SDLP  in both  the  simulator  and  on  the test  track  (p < 0.001  for  both).  In
the simulator,  this  dose–response  was evident  already  after  15  min  of  driving.  SDLP  values  were  higher
and showed  a  larger  inter-individual  variability  in the  simulator  than  on  the  test track.  Most  subjects
displayed  a similar  relationship  between  BAC  and  SDLP  in  the  simulator  and  on  the  test  track;  however,  a
few  subjects  showed  striking  dissimilarities,  with  very  high  SDLP values  in the  simulator.  This  may  reﬂect
the lack  of perceived  danger  in  the  simulator,  causing  reckless  driving  in  a few test  subjects.  Overall,  the
results suggest  that SDLP  in the  driving  simulator  is  a sensitive  measure  of ethanol  impaired  driving. The
comparison  with  real driving  implies  relative  external  validity  of  the  simulator.. Introduction
Impaired driving caused by ethanol and/or drugs is a major
ause of trafﬁc accidents, and thus a major public health problem
Blomberg et al., 2009). The relationship between blood ethanol
oncentrations (BAC) and accident risk is well established in
arge epidemiological studies (Borkenstein et al., 1974; Blomberg
t al., 2009). With the exception of cannabis (Ramaekers et al.,
004), similar relationships have not been demonstrated for other
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ax: +47 72 82 91 10.
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001-4575 © 2013 Elsevier Ltd.
ttp://dx.doi.org/10.1016/j.aap.2012.12.042
CC BY-NC-ND license.Open access under© 2013 Elsevier Ltd.
psychoactive drugs and drugs of abuse. Case–control studies on
non-alcohol drugs require screening and quantiﬁcation of a large
number of potentially impairing drugs, as well as a large number
of cases, as each drug has a relatively low prevalence of detection
in car crash drivers. Such studies have seldom been performed,
leaving the relation between blood drug concentrations and crash
risk largely unknown. Also, blood sampling for drug testing of con-
trols – as compared to simple breath tests in ethanol studies – is
necessary, and makes the recruitment of controls more difﬁcult
(Verster et al., 2009a).  Furthermore, post-mortem drug concentra-
tion changes occur to a larger degree in non-alcohol drugs, making
CC BY-NC-ND license.Open access underinterpretation of toxicological data from studies of killed drivers
difﬁcult.
Epidemiological approaches cannot establish causal relation-
ships, and are fraught with methodological difﬁculties, including
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he possibility of confounding factors. Thus, experimental stud-
es are crucial to investigate the impairing effects of drugs and
he relationship between drug concentrations, impaired perfor-
ance and possible accident risk. All experimental settings are a
riori artiﬁcial, and may  thus have limited external validity when
pplied to real driving conditions. For instance, laboratory testing of
ognitive and psychomotor functioning may  measure some skills
hat are considered essential to safe driving, but can never fully
eproduce the complexity of actual driving. Real on-road driving
ith measurements of standard deviation of lateral position (SDLP)
as come to be considered the method of reference for assessing
riving impairment from CNS depressant drugs (Verster et al.,
004), although this measure reﬂects mainly one (i.e., automatic
ehaviour) of the three “core levels” of driving (Walsh et al., 2008).
uch of the on-road experiments have so far been conducted in The
etherlands on ﬂat, straight multi-lane motorways; a driving sce-
ario that may  not reﬂect conditions elsewhere. Also, legal issues
nd safety considerations may  hinder on-road experiments, and
he costs of such experiments may  be prohibitive.
Experimental studies utilising driving simulators may  avoid
ome of the problems listed above. However, even very sophis-
icated simulators cannot fully replicate real driving conditions
Verster et al., 2004; Shechtman et al., 2009). Driving simulator
tudies of effects of depressant drugs on driving ability frequently
ield inconclusive results due to the lack of validation against a
nown positive control; in practice, ethanol. The positive control
s necessary to ensure that correlations between drug intake and
riving related outcome measures actually reﬂect a drug related
mpairment of driving ability, and not simply randomly observed
orrelations with no relevance to impairment (Walsh et al., 2008).
thanol as a positive control also ensures that the experimental
esign is sufﬁciently sensitive to the impairing effects of depres-
ant drugs. Another common limitation of driving simulators is the
ack of validation against a real driving scenario; i.e., the external
alidity. This leaves doubt as to whether test subject performance
n the simulated scenario may  predict performance in real driving
ituations.
We wanted to develop a valid and functional tool for assessing
rug effects on driving performance, taking into account the rec-
mmendations made in the guidelines for research on drugged
riving. To achieve this, we conducted a validation study of the SIN-
EF driving simulator. The purpose of the study was to establish a
riving simulator test battery that is sensitive to ethanol effects,
nd to validate the test battery by comparing performance in the
imulator with actual driving performance on a closed-circuit test
rack resembling rural driving conditions. Even though both simu-
ator and closed circuit driving constitute experimental conditions,
hich do not fully reproduce the real life driving experience, both
re widely used for assessing driving performance, and real driv-
ng is generally considered to be the reference methodology as far
s validity is concerned. In this paper we present results from the
rimary outcome measure SDLP, measured in the simulator and on
he test track.
. Materials and methods
.1. Test subjects
Twenty healthy, Caucasian, male volunteers aged 25–35 years
mean 28.7 years) who had been in possession of a driver’s license
or at least 5 years (mean 10.6 years), were included in the study.
hey were all recreational users of alcohol, and as a group drove
lightly less and had a somewhat higher educational level than
he general population. Women  and non-Caucasians were excluded
ecause of the teratogenic risk associated with ethanol use in theFig. 1. Outline of trial test design.
former group, and the possibility of deviant ethanol metabolism
in the latter. The other exclusion criteria were previous or present
drug or alcohol abuse or atypical reactions to alcohol, previous his-
tory of driving under the inﬂuence, signiﬁcant adverse reactions to
previous blood sampling, regular (daily) intake of any prescribed
drug, or high likelihood of motion sickness as assessed with a modi-
ﬁed version of the Apfel risk score for postoperative vomiting (Apfel
et al., 1998). Each participant underwent a screening for eligibility,
received written and oral information about the study and provided
a written consent to participate. The study was approved by the
Regional Ethics Committee, and was registered as a clinical trial in
the ClinicalTrials.gov database. All participants received a gift cer-
tiﬁcate worth NOK 1000 (approx. USD 150) upon completion of the
study.
2.2. Trial design
The experiment was  designed as a randomised, placebo-
controlled, single blind, crossover study. Only the necessary
personnel were informed about which interventions were given. An
outline of the design is presented in Fig. 1. Each participant under-
went three driving tests of 1 h duration, both on a closed-circuit test
track and in an advanced driving simulator, on six different test days
with washout periods of minimum two  days between test days to
allow the dissipation of any learning or fatigue effects. The driving
scenario in the simulator was modelled to mimic  the test track, as
illustrated in Fig. 2, to ensure that the driving experience would
be as similar as possible in the two  test conditions. Before test-
ing commenced, the study subjects undertook a training session,
both on the test track and in the simulator, in order to familiarise
themselves with the testing scenario and minimise the impact of
possible learning effects. On test days, the participants were obliged
to deliver a urine sample on arrival at the test site to exclude the
presence of drugs. The subjects’ weight was  registered each test
day, after which they were administered a weight-adjusted dose of
ethanol (0, 0.7 and 1.05 g per kg body weight), calculated to obtain
an intended blood alcohol concentration (BAC) during testing of
0, 0.5 and 0.9 g/L on the three different test days both in the sim-
ulator and on the test track, respectively. The Widmark equation
(Andréasson and Jones, 1995), was used to estimate the ethanol
doses, assuming a total body water to total body mass ratio of 0.68,
a bioavailability of 75%, and a metabolic rate for ethanol of 0.15 g/L
per hour. We used vodka mixed with fruit extracts, orange and lime
juice to make the drinks palatable. The placebo drinks were spiked
with non-alcoholic vodka ﬂavour in water to mimic the vodka taste.
The drinks were served in closed plastic containers, from which
the participants were instructed to sip the drink through a straw.
To avoid an obvious ethanol taste, no drinks were stronger than
10% (v/v) ethanol, and they were kept cold by the addition of ice.
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to correlate with BAC levels in a dose dependent manner, and is
a thoroughly validated measure of the degree of driving impair-
ment (Verster et al., 2004). Secondary outcome measures were
number of brake pedal pressures per lap, number of acceleratorFig. 2. Example of the driver’s visual impression on the cl
he participants were allowed 1 h to ﬁnish their drinks, after which
hey waited another 30 min  before the driving test started, to allow
or absorption of the administered ethanol. The order in which the
articipants were tested at different BAC levels was  randomised by
se of a counterbalanced, multi-condition design. The same order
f BAC levels was used for each participant both on the test track
nd in the simulator. As an additional confounder to enhance blind-
ng, the study subjects were administered a placebo pill, which
hey were told may  or may  not contain a sedative drug, with the
rink. Venous blood samples were drawn immediately before and
fter each driving session, and the mean value was used as the best
stimate of the mean BAC during testing.
.3. Real driving on test track
The test track driving was undertaken during a frost-free period
f six weeks in the autumn. All study sessions were done after night-
all, between 20:00 and 01:00 h. The test track circuit was 1.37 km
ong, closed to ordinary trafﬁc, and laid out in hilly terrain, with both
entle and sharper curves. The track was hard-surfaced, with two
anes each approx. 2.75 m wide, and had midline and side markings
imilar to standard Norwegian road markings. Thus, the test track
losely resembled roads typical of rural Norway. Surprise obstacles
1 m3 foam rubber cubes) were placed in two locations on two  occa-
ions, one at the beginning and one towards the end of each driving
rip, and were to be avoided by the test subjects. Stoplights present
n two locations turned red on one occasion during each trip. The
articipants drove an instrumented car (Volvo V70 2.4s) with auto-
atic transmission, ﬁtted with a double set of pedals. They were
nstructed to drive as they would normally do on a regular road. A
rofessional driving instructor was present in the front passenger
eat during all sessions of test track driving, in order to intervene
f necessary. A physician was present on the site at all times dur-
ng test drives. Permission to carry out the test track driving was
ranted from the local police. To enable continuous recording of
ateral position in the road lane, the test car was equipped with an
nfrared wide-angle camera ﬁxed to the roof of the car, and pointing
t a downward angle to the rear of the car. The data were stored in a
atabase and analysed in a program for photo analysis (Open Source
omputer Vision Library). A ﬁltering algorithm (Hough transforma-
ion) was used to identify roadside markings. The car also featured
ther equipment for recording the location of the car on the test cir-
uit (global positioning system; GPS), speed, pedal use and steering
heel movements..4. Driving simulator
Testing in the driving simulator took place in late autumn after
he test track driving tests were completed. Test sessions wereircuit test track (left) and in the driving simulator (right).
done at the same times during the evening and night as on the
test track, using a virtual model of the test track and a night-
time scenario (Fig. 2), to ensure comparable results and eliminate
differences in circadian inﬂuences. In addition to obstacles and
stoplights, the simulator scenario also included two  incidents (a
car abruptly entering the road and a pedestrian crossing the road in
front of the driver) that each occurred once at the end of the driving
session. The simulator had the appearance of a regular car (Renault
Scenic) with automatic transmission and original controls (Fig. 3).
Information from the use of steering wheel, pedals, transmission
etc. was  fed into a dedicated driving scenario graphics computer.
The driving scenario was  depicted on screens covering 180◦ of the
driver’s forward ﬁeld of vision and 90◦ of the rear ﬁeld of vision,
and synchronously in internal and external mirrors. The vertical
ﬁeld of view was  47◦ both to the front and to the rear. The simu-
lator reproduced realistic motion, vibration and sound through a
three-axis moving platform, a vibration system in the chassis and
a four-channel sound system. Data on lateral position, speed, pedal
use and steering wheel movements over the entire duration of the
test sessions were extracted directly from the simulator computer
and logged 20 times per second. A detailed description of the SINTEF
simulator can be found in Engen (2008).
2.5. Measurements
The predeﬁned primary outcome measure was the standard
deviation of lateral position (SDLP), which is a measure of the
degree of weaving of the car on the road. SDLP has been shownFig. 3. Setup of the driving simulator. Vehicle and surrounding frontal screens.
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Table 1
Measured blood ethanol concentrations (BAC) in simulator driving and on test track
at the three designated BAC levels of 0, 0.5 g/L and 0.9 g/L among all test subjects
with samples.
Test scenario Intended BAC Mean BAC (±SD)
Simulator (n = 19) 0 0
0.5  g/L 0.38 (±0.10) g/L
0.9  g/L 0.82 (±0.19) g/L
Test track (n = 20) 0 02 A. Helland et al. / Accident An
edal pressures per lap, steering wheel movement speed, steering
heel movement per lap, steering wheel reversals per lap, steer-
ng wheel reversal frequency, average speed, standard deviation
f speed (measured continuously throughout the driving sessions),
riving behaviour at unexpected incidents, and driving against red
ight. We  aim to present the secondary outcome measures in a
ubsequent article.
Before and after each driving session, the participants com-
leted a questionnaire, with items covering their feelings of
ntoxication, mastery, safety, sleepiness, alertness, whether they
hought the drink had contained ethanol, and whether they thought
he pill had contained a sedative drug. At the test track, driving
nstructors were also asked to rate the test subjects’ degree of intox-
cation and driving performance.
Blood ethanol concentrations were quantiﬁed using a headspace
as chromatography–mass spectrometry (GC–MS) method. In
rief, 200 L blood was mixed with 50 L internal standard (d6-
thanol). Samples were left for 30 min  to achieve equilibrium
efore the gas fraction was aspirated into an Agilent HP 6890-5973
C–MS system (Agilent, Palo Alto, CA). Separation was performed
n a J&W Scientiﬁc 123-9134 DB-ALC1 (30 m × 1.2 mm)  column
ith a helium mobile phase and a run time of 0.90 min. Ethanol was
onitored at m/z 31 and the internal standard at m/z 33. The level of
uantiﬁcation (LOQ) was 2 mmol/L (approx. 0.09 g/L). Between-day
oefﬁcient of variation (CV) calculated from quality control samples
as 4.5% at 5 mmol/L (0.22 g/L) and 1.8% at 50 mmol/L (2.2 g/L).
.6. Statistical analyses
An a priori sample size estimation performed with one-tailed,
aired t-tests indicated that a total sample size of n = 11 would be
ufﬁcient to detect signiﬁcant differences in BAC level inﬂuence
n SDLP with signiﬁcance level (˛) of 0.05 and power (1−ˇ) of
.95. Although theoretically 11 subjects would sufﬁce, we chose to
nclude 20 subjects in the study, to allow for the uncertainty in the
nderlying assumptions of the sample size estimation, as well as
he possibility of dropouts, for instance due to simulator sickness.
In the results analyses, we used a linear mixed model with SDLP
s dependent variable, measured BAC as covariate, and partici-
ant as random effect. Separate analyses were performed for test
rack and simulator. Reported results are from restricted maximum
ikelihood estimation. The maximum likelihood estimation did not
lways converge. The independent variables tested for signiﬁcance
ere BAC level, curved/straight section and part of trip driven (each
rip was divided in four equal parts of 15 min). To identify possi-
le learning effects that could interfere with the results, the impact
f the number of trips driven before the actual one was  also ana-
ysed. Two-sided p-values <0.05 were considered signiﬁcant. The
nalyses were performed in SPSS 18 and Stata 12.
. Results
Of the 20 participants enrolled in the study, all completed three
riving sessions on the test track, while 18 out of 20 completed
ll three sessions in the driving simulator. Two subjects did not
omplete the simulator testing; one because of intolerable nau-
ea, and the other because of a surgical procedure unrelated to the
tudy. On the test track, 10 out of the 60 driving sessions did not
ield sufﬁcient SDLP data to be included in the analyses. The car-
ounted camera was out of position in eight sessions, the camera
as not switched on in one instance, and one participant in his
rst session misinterpreted the instructions to drive in lane. Thus,
 complete set of outcome data was obtained from 10 participants
n the test track and 18 participants in the simulator. Data from the
alid driving sessions of all subjects were included in the analyses.0.5  g/L 0.42 (±0.09) g/L
0.9  g/L 0.88 (±0.12) g/L
3.1. Safety and adverse events
No safety violations or serious or unexpected adverse events
occurred during the study. The most common adverse event in the
simulator was nausea, which is a known disadvantage of driving
simulators. Six subjects (four at BAC 0 and two  at BAC 0.5) had
to terminate their ﬁrst simulator session early because of this, but
ﬁve of them were eventually able to complete all three sessions.
Thus, only one subject had to withdraw from the study due to
nausea. Prior experience suggests that ethanol may  protect against
simulator sickness, and repeated exposures to the simulator tend
to attenuate the nausea. Therefore, in order to prevent dropouts,
all participants who terminated their sessions early due to nausea
were tested at the highest BAC level in the subsequent session. The
random order was  also modiﬁed in an additional three subjects due
to other practical causes. These modiﬁcations to the randomisation
did not affect concealment of the interventions, and did not appear
to introduce systematic bias, since there was no statistically sig-
niﬁcant correlation between BAC level and the number of previous
test sessions (Pearson correlation 0.241 (p = 0.080) in simulator and
0.094 (p = 0.477) on test track).
3.2. Blood alcohol concentrations
The ethanol concentrations are presented in Table 1. Ethanol
concentrations were slightly lower than intended both in the sim-
ulator and on the test track, with concentrations closer to 0.4 g/L
at the intended level of 0.5 g/L. The BAC also tended to be slightly
lower in the simulator than on the test track. Paired sample t-test
showed a statistically signiﬁcant difference between the BAC levels
in simulator and on test track for the designated BAC level of 0.5 g/L
(p = 0.041); however, the mean difference was  only 0.039 g/L. For
the designated BAC level of 0.9 g/L, there was no statistically sig-
niﬁcant difference between BAC levels in simulator and on test
track (p = 0.21). In the following, ethanol levels are referred to as
the intended levels (BAC 0, BAC 0.5 and BAC 0.9, respectively).
3.3. Questionnaires
After each driving session, the participants were asked whether
they thought the drink and the pill had contained alcohol and a
sedative drug, respectively. Most subjects correctly identiﬁed the
drink as containing/not containing ethanol (in 32 of 38 placebo tri-
als, 35 of 38 BAC 0.5 trials and 37 of 38 BAC 0.9 trials, respectively).
However, a few misidentiﬁed their drinks, and quite a few wrongly
identiﬁed the pill as containing a sedative drug (in 15 of 38 placebo
trials, 3 of 38 BAC 0.5 trials and 7 of 38 BAC 0.9 trials, respectively).
There were signiﬁcant correlations between higher BAC levels
and subjective (self reported) ratings of poorer driving perfor-
mance both in the simulator (R = 0.35, p = 0.013) and on the test
track (R = 0.63, p < 0.001). Likewise, there was a strong correla-
tion between higher BAC levels and objective (driving instructor
A. Helland et al. / Accident Analysis and Prevention 53 (2013) 9– 16 13
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nd  on test track (right; open circles). The circles represent individual BAC and th
hown as continuous lines and broken lines, respectively.
eported) ratings of poorer driving performance on the test track
R = 0.52, p < 0.001).
.4. SDLP
Fig. 4 shows the individual SDLP values at the corresponding
AC, with the estimated regression line and its 95% conﬁdence
nterval. Both in the simulator and on the test track, there were
igniﬁcant positive correlations between BAC and SDLP (positive
egression slope with p < 0.001). The estimated regression lines for
he simulator (Eq. (1))  and the test track (Eq. (2))  are as follows,
ith standard errors for the estimates in parentheses:
simulator) : SDLP (cm) = 29.43 (±2.57) + 13.20 (±3.61) × BAC (1)
test track)  : SDLP (cm) = 22.30 (±1.89) + 7.61 (±1.91) × BAC (2)
SDLP values were higher in the simulator than on the test track
t baseline (placebo) conditions (29.4 cm vs. 22.3 cm,  respectively),
nd showed a steeper increase with increasing BAC, as seen from
qs. (1) and (2),  as well as Fig. 4. As evident from Fig. 4, SDLP variance
as also larger in simulator driving than in test track driving.
The relationship between BAC levels and SDLP results show a
ose–response effect, as quantiﬁed by the slopes 13.20 and 7.61 in
q. (1) and (2).  Furthermore, a visual comparison of SDLP results
n the simulator and on the test track in each of the 20 individual
ubjects shows similar, positive slopes in most subjects (Fig. 5).
To identify possible differential effects of test duration and
urved/straight sections on SDLP, the SDLP results were analysed
ith respect to time intervals (four equal intervals of 15 min  each),
nd performance on curved and straight sections of the driving sce-
ario. In the simulator, mean SDLP values were signiﬁcantly higher
n curved sections than in straight sections (p = 0.047), whereas
here were no such differences on the test track (p = 0.17). In the
imulator, statistically signiﬁcant differences in SDLP between BAC
evels were seen in all four time intervals. On the test track, the
ifferences in SDLP were similar but less pronounced, and mostly
id not reach signiﬁcance during the ﬁrst half hour of the test. In
he simulator, there was a trend towards higher SDLP values with
onger test duration, especially at the highest BAC level. No such
endency was evident on the test track.
To identify possible learning effects that would be expected
o reduce SDLP with the number of prior test sessions, the num-
er of trips driven before the actual one was also analysed as an) and standard deviation of lateral position (SDLP) in simulator (left; ﬁlled circles)
sponding SDLP value. The regression lines and their 95% conﬁdence intervals are
independent variable. However, this had no statistically signiﬁcant
correlation with SDLP results either in the simulator (p = 0.70) or
on the test track (p = 0.66).
4. Discussion
4.1. SDLP
Our results show a positive dose–response correlation between
BAC and SDLP in the simulator and on the test track, both for
individual and mean data. A high degree of intra-individual sim-
ilarity in the BAC-correlated increase in SDLP in the simulator
and on the test track, suggests that SDLP is a valid and sen-
sitive measure of ethanol-induced driving impairment in the
simulator.
Absolute values of SDLP were higher in the simulator than on
the test track, with mean SDLP at BAC 0 (sober state) of 29 cm and
22 cm, respectively. SDLP values during placebo conditions in the
simulator were also considerably higher than those seen in Dutch
on-road driving tests, where mean baseline SDLP is approx. 19 cm
(range 9–30 cm)  (Verster and Roth, 2011). The relatively demand-
ing driving scenario that was  used in our experiment may account
for the slightly higher SDLP values on the test track than those seen
during previous on-road tests. Higher absolute SDLP values in the
simulator compared to real driving may  be explained by unfa-
miliarity with the driving experience in the simulator, a lack of
perceived danger, and lack of gravitational cues and feedback that
will normally adjust steering. This notion is also supported by the
observation that SDLP values were higher in curved sections than
in straight sections in the simulator, whereas such a difference was
not observed on the test track. Together with the more demand-
ing driving scenario in our experiment, this may account for the
considerably higher SDLP values than those seen for instance in
the Dutch STISIM simulator employing a monotonous highway sce-
nario (Mets et al., 2011b).
Most test subjects showed similar SDLP increases in the sim-
ulator and on the test track. However, from the individual SDLP
data shown in Fig. 5, a few subjects behave differently, evidenced
by excessive SDLP values in the simulator. For instance, test subject
no. 15 had a mean SDLP exceeding 1 m at the highest BAC level. This
would correspond to the car being located mostly out of lane during
the trip, which is in accordance with the actual observations made
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evel  in the simulator were 0.79 g/L and 102 cm,  respectively.
uring this individual’s simulator driving. It is our experience from
he present and earlier simulator experiments that some partici-
ants regard the simulator as a kind of game and behave more like
irtual rally drivers instead of following the instructions to drive
ppropriately according to conditions. This can explain the large
iscrepancies in SDLP between test track and simulator seen in a
ew of the subjects. Subject no. 14 attained an unexpectedly high
AC at his highest BAC level in the simulator (1.25 g/L), which may
xplain the high SDLP observed in that driving session. Also, we
annot exclude the possibility that some participants’ SDLP scores
ere inﬂuenced by simulator sickness.
.2. BAC
Mean subjective and objective ratings of intoxication and driv-
ng performance correlated with BAC level in the expected manner.
he somewhat lower BAC levels in simulator than on test track may
e due to a possible conditioned nausea response in the simulator
hat could have caused retention of stomach content with delayed
thanol absorption. One participant (subject no. 6) was unable toack (open circles). For test subject 15, the BAC and SDLP values at the highest BAC
ﬁnish his drink at the intended BAC 0.9 level in the simulator, and
consequently acquired a low BAC.
Most participants correctly identiﬁed their drink as contain-
ing/not containing ethanol and the pill as containing/not containing
a sedative drug, although quite a few of the participants misiden-
tiﬁed the placebo pill, especially in the BAC 0 trials. This probably
reﬂects an expectation bias in some subjects, and indicates that
the use of placebo pills to enhance blinding of the interven-
tion in experimental trials with ethanol may  be worthwhile.
Previous experience suggests that concealment of ethanol is dif-
ﬁcult in blinded studies due to the distinctive taste and smell and
the characteristic and familiar effects of ethanol.
4.3. Comparison with other driving simulator studies and
on-road testsTo date, there are few other studies validating the use of
driving simulators for drug and/or ethanol impairment research.
A simulator validation study published in 2009 used data from
two separate previous studies (on-road and in simulator). The
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escription of the simulator they used suggests that it was  simi-
ar to the SINTEF simulator, but the driving scenario and outcome
easure were different (urban trafﬁc and number of driving errors
t intersections as assessed by a driving instructor, respectively). No
thanol or other drugs were used. Results indicated relative valid-
ty for the simulator, and suggested absolute validity for the type
f errors pertaining lane maintenance, adjustment to stimuli and
isual scanning (Shechtman et al., 2009).
There are few previous simulator studies using SDLP as out-
ome measure. Only one study has validated SDLP as an indicator of
nsafe driving in the simulator that was used. Mets et al. published
 validation study in 2011 showing the ability of the STISIM driving
imulator to differentiate between different BAC levels based on
DLP results. In this study, 27 healthy volunteers underwent a sim-
lator adaptation of the standardised Dutch on-road test scenario
multi-lane highway driving for 1 h). BAC levels of 0 g/L, 0.5 g/L,
.8 g/L and 1.1 g/L yielded mean SDLP values of 28.0 cm,  29.7 cm,
3.8 cm and 36.3 cm,  respectively. This study did not validate the
imulator results against a real driving test (Mets et al., 2011b).
part from this, only two simulator studies concerning driving per-
ormance after drug intake have been published using SDLP as an
utcome measure. Mets et al. have investigated the effects of caf-
eine (given in the form of the energy drink Red Bull® and coffee,
espectively) on driving performance in healthy volunteers in two
tudies in the Dutch STISIM simulator, and found small but signiﬁ-
ant reductions in SDLP after caffeine administration in both studies
Mets et al., 2011a, 2012).
In 2009, a validation study with ethanol in a divided-attention
teering simulator (DASS) was published. As the name suggests,
he simulator is designed to measure ability of divided attention.
ccordingly, it employs a rather artiﬁcial test scenario, where sub-
ects must keep the car in lane and simultaneously respond to
eripheral visual stimuli. Also, the simulator used did not resemble
 normal car. Dose-dependent impairment was found with higher
thanol levels (Verster et al., 2009b).
The standardised on-road driving test with SDLP as the outcome
easure developed in The Netherlands remains the method of ref-
rence to examine driving impairment from drugs. In such testing,
AC levels of 0.5 g/L and 0.8 g/L on average increases SDLP from
lacebo conditions with 2.4 cm and 4.3 cm,  respectively (Verster
nd Roth, 2011). Our results from the test track show slightly larger
ncreases in SDLP, whereas the BAC-related increases in the sim-
lator were considerably larger. Again, the discrepancy between
ur results and the Dutch on-road results may  be explained by
he more demanding driving scenario employed in our validation
tudy.
.4. Implications for the validity and further use of the simulator
External validity of a driving simulator refers to the test sce-
ario’s ability to invoke similar reactions in the drivers as a real
riving scenario. Validity is speciﬁc for the particular type of sce-
ario and simulator, test, and population used in the validation
xperiments, and will not necessarily be transferable to other driv-
ng scenarios, simulators, tests, or populations. External validity is
bsolute if the same effect is invoked to the same extent both in
he simulator and in the real driving environment. Relative exter-
al validity implies that there exists a trend of change in the same
irection both in the simulator and in the real driving environ-
ent, but the magnitude of change is different (Shechtman et al.,
009).
There was a large degree of similarity in the relationship
etween SDLP and BAC levels in the simulator and on the test
rack. However, the absolute values of SDLP in the simulator were
onsistently higher than on the test track. Thus, the relative (but
ot the absolute) external validity of the SINTEF simulator has and Prevention 53 (2013) 9– 16 15
been established when validated against test track driving in a
driving scenario that is representative of the demanding rural
driving conditions in Norway, using ethanol as a positive control.
We believe that this validation may  be extended to real driving
under similar conditions; however, this assumption has not been
proven.
In the simulator, we found consistent and signiﬁcant BAC-
related increases in SDLP in all time intervals when the
hour-long test was divided into four 15-min time inter-
vals. This suggests that the duration of the simulator test in
order to reach signiﬁcant results may  be shortened in future
studies.
4.5. Limitations of the study
In our study, all test subjects were healthy young male vol-
unteers, who are not representative for the general driving
population. Our results may  therefore give a somewhat inaccu-
rate estimation of the impact of BAC on SDLP in the general
population.
There are three levels of behaviour relevant to trafﬁc safety:
automatic, control and executive planning behaviour (Michon,
1985; Walsh et al., 2008). SDLP as the primary outcome measure
in this study is mainly representative for the effect of ethanol on
automated actions at a behavioural control level. Outcome meas-
ures of driving behaviour at manoeuvring and strategic levels will
be reported in a separate publication. Driving simulators may  be
especially suitable to test higher behavioural levels like hazard
avoidance, dual attention, risk taking and impulsivity, both for
ethical (risk of injury) and practical (ease and reliability of mea-
surements) reasons.
We  employed a single blind design, keeping the intervention
concealed from the test subjects but not from the study personnel
or those responsible for analysing the outcome data.
Unlike some of the most advanced simulators in use, the
SINTEF simulator allows only limited tilting (three degrees of free-
dom). Motion-based simulators with full tilting technology might
increase the realism of the driving experience, and thus heighten
the external validity of the simulator.
Several of the test subjects experienced nausea in the simula-
tor, which caused one subject to withdraw from the study, and
may  have affected driving behaviour in others. This is a general
drawback of driving simulators, which may to some extent be
unavoidable, even when using screening procedures including test
drives before enrolment. We  also employed a rather challenging
driving scenario, with many curves and long duration, which may
have exacerbated the problems related to nausea.
The validation against real driving was done on a closed test
track. The length (approx. 1.4 km)  and layout (curvy, hard-top road
approx. 5.5 m wide with midline and side markings) of the test track
ensured that the driving experience resembled real driving on rural
Norwegian roads. However, it may  be impossible to fully eliminate
the feeling of an artiﬁcial situation when driving on a closed test
track. For safety reasons, a driving instructor was  present in the
passenger seat at all times on the test track, as well as a police ofﬁcer
on the test track site. This may  have constituted a restraining effect
as well as heightened the attention of test subjects, causing them
to drive more carefully and attentively than they would otherwise
have done.
Finally, our study had a limited sample size, which generally
increases the risk of type II errors (i.e., failing to detect real differ-
ences). Also, missing data from 10 of 60 driving sessions on the test
track may  have limited the statistical signiﬁcance of our ﬁndings.
The missing data occurred due to random incidents, and we  have
no reason to believe this introduced systematic bias.
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. Conclusions
In healthy volunteers, SDLP as a measure of drug-impaired
riving shows qualitatively similar outcomes during test track driv-
ng and in a driving simulator designed to mimic  the test track,
oth sober and under the inﬂuence of ethanol. However, SDLP is
mpliﬁed in the simulator as compared to real driving. Although
losed circuit driving is an experimental situation and thus of
imited external validity, the quantitative and qualitative similar-
ties between simulator and test track driving nevertheless imply
xternal validity of the simulator. In conclusion, the SINTEF driving
imulator is a sensitive and valid tool to assess driving impair-
ent from ethanol, and this may  be extended to include other CNS
epressant drugs.
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